March 9, 2020 / 12:28 PM / 20 days ago

BRIEF-Minerva Neurosciences Posts Q4 loss per share of $0.77

March 9 (Reuters) - Minerva Neurosciences Inc:

* MINERVA NEUROSCIENCES REPORTS FISCAL 2019 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS AND BUSINESS UPDATES

* Q4 LOSS PER SHARE $0.77

* Q4 EARNINGS PER SHARE ESTIMATE $-0.38 — REFINITIV IBES DATA

* CONFIRMS TIMING OF EXPECTED TOP-LINE RESULTS FROM PHASE 3 ROLUPERIDONE TRIAL IN Q2 2020

* MINERVA NEUROSCIENCES - CASH, CASH EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES AS OF DEC 31, 2019 WERE ABOUT $46.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below